Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
To monitor innate immune responses in the CNS, the 18 kDa Translocator protein (TSPO) is a frequently used target for PET imaging. The frequent assumption that increased TSPO expression in the human CNS reflects pro‐inflammatory activation of microglia has been extrapolated from rodent studies. However, TSPO expression does not increase in activated human microglia in vitro. Studies of multiple sclerosis (MS) lesions reveal that TSPO is not restricted to pro‐inflammatory microglia/macrophages, but also present in homeostatic or reparative microglia. Here, we investigated quantitative relationships between TSPO expression and microglia/macrophage phenotypes in white matter and lesions of brains with MS pathology. In white matter from brains with no disease pathology, normal appearing white matter (NAWM), active MS lesions and chronic active lesion rims, over 95% of TSPO+ cells are microglia/macrophages. Homeostatic microglial markers in NAWM and control tissue are lost/reduced in active lesions and chronic active lesion rims, reflecting cell activation. Nevertheless, pixel analysis of TSPO+ cells (n = 12,225) revealed that TSPO expression per cell is no higher in active lesions and chronic active lesion rims (where myeloid cells are activated) relative to NAWM and control. This data suggests that whilst almost all the TSPO signal in active lesions, chronic active lesion rims, NAWM and control is associated with microglia/macrophages, their TSPO expression predominantly reflects cell density and not activation phenotype. This finding has implications for the interpretation of TSPO PET signal in MS and other CNS diseases, and further demonstrates the limitation of extrapolating TSPO biology from rodents to humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017 · cited 1×
“Human brain tissues were obtained from 19 MS patients diagnosed by the McDonald criteria (Polman et al., 2005) and six age-matched controls with non-neurological conditions (Table 1).”
MethodNormality Tests for Statistical Analysis: A Guide for Non-Statisticians
Ghasemi, A., & Zahediasl, S. (2012) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.3505 · Cited by 4,368 · cited 1×
“…(LN3) Mouse Biolegend 327,011 1:750 IBA-1 Rabbit Wako 1,919,741 1:10.000 TSPO (PBR) Goat Novus Biologicals NB100-41398 1:750 P2RY12 Rabbit ANASPEC AS55042A 1:200 TMEM119 Rabbit Merck HPA051870 1:250 tested for normal distribution, using the Shapiro–Wilk normality test (Ghasemi & Zahediasl, 2012).”
InfluentialIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
Microglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“…predominantly express all three commonly used markers CD68, IBA-1 and HLA-DR suggesting that these cells have the capacity to scavenge, present antigens as well as phagocytose debris from their environment (Hendrickx et al., 2017; Ito et al., 1998; Ohsawa et al., 2004; Sasaki et al., 2001).”
BackgroundSingle cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
Olah, M., Menon, V., Habib, N., Taga, M. F., Ma, Y., Yung, C. J., Cimpean, M., Khairallah, A., Coronas-Samano, G., Sankowski, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19737-2 · Cited by 722 · cited 2×
“Similarly, TSPO mRNA was reported to be equal among all different microglia clusters in Alzheimer's disease (Olah et al., 2020).”
BackgroundResultLoss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684 · cited 7×
“In control and NAWM tissue, microglia and macrophages predominantly expressed IBA-1 and CD68 but not HLA-DR, indicating that HLA-DR expression arises during activation of microglia in active MS lesions, corroborating previous studies (Zrzavy et al., 2017).”
BackgroundResultInfluentialThe peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Cosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459 · cited 1×
“…TSPO PET signal in the white matter originates from microglia, except in the proportionally smaller volumes of inactive lesions, in which most of the signal must originate from astrocytes (Banati, 2003; Cosenza-Nashat et al., 2009; Nutma et al., 2019; Veronese et al., 2018; Wimberley et al., 2018).”
BackgroundTMEM119 marks a subset of microglia in the human brain
Satoh, J., Kino, Y., Asahina, N., Takitani, M., Miyoshi, J., Ishida, T., & Saito, Y. (2016) · Neuropathology · doi:10.1111/neup.12235 · Cited by 434
Venneti, S., Lopresti, B. J., & Wiley, C. A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.10.002 · Cited by 373
Iba1 Is an Actin-Cross-Linking Protein in Macrophages/Microglia
Sasaki, Y., Ohsawa, K., Kanazawa, H., Kohsaka, S., & Imai, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5388 · Cited by 373 · cited 1×
“…predominantly express all three commonly used markers CD68, IBA-1 and HLA-DR suggesting that these cells have the capacity to scavenge, present antigens as well as phagocytose debris from their environment (Hendrickx et al., 2017; Ito et al., 1998; Ohsawa et al., 2004; Sasaki et al., 2001).”
BackgroundInnate Immunity and Neurodegeneration
Labzin, L. I., Heneka, M. T., & Latz, E. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104343 · Cited by 319 · cited 1×
“One potential explanation for this is that innate immune responses, particularly microglia activation linked to aging of the CNS and the immune system, may be a major contributing factor in neurodegeneration and irreversible disease progression (Labzin et al., 2018).”
BackgroundHendrickx, D. A. E., van Eden, C. G., Schuurman, K. G., Hamann, J., & Huitinga, I. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.04.007 · Cited by 313
Transcriptional control of microglia phenotypes in health and disease
Holtman, I. R., Skola, D., & Glass, C. K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90604 · Cited by 218 · cited 1×
“Microglia adopt intricate and complicated phenotypes that cannot be well defined by single markers (Holtman et al., 2017; Vogel et al., 2014; Zrzavy et al., 2017).”
BackgroundKaunzner, U. W., Kang, Y., Zhang, S., Morris, E., Yao, Y., Pandya, S., Hurtado Rua, S. M., Park, C., Gillen, K. M., Nguyen, T. D., et al. (2019) · Brain · doi:10.1093/brain/awy296 · Cited by 199 · cited 1×
“This is consistent with our previous findings, showing that approximately 65% of the total population of TSPO+ cells in inactive lesions are astrocytes (Dickens et al., 2014; Kaunzner et al., 2019; Nutma et al., 2019).”
ResultOwen, D. R., Narayan, N., Wells, L., Healy, L., Smyth, E., Rabiner, E. A., Galloway, D., Williams, J. B., Lehr, J., Mandhair, H., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17710182 · Cited by 194 · cited 5×
“…reflect activated pathogenic microglia, the early assumption that TSPO expression increases in human microglia as they become activated was inferred from animal studies using rodents (Bae et al., 2014; GottfriedBlackmore et al., 2008; Karlstetter et al., 2014; Owen et al., 2017; Wang et al., 2014).”
BackgroundInfluentialSelf-citationPeferoen, L. A. N., Vogel, D. Y. S., Ummenthum, K., Breur, M., Heijnen, P. D. A. M., Gerritsen, W. H., Peferoen-Baert, R. M. B., van der Valk, P., Dijkstra, C. D., & Amor, S. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000149 · Cited by 178
Self-citationvan Wageningen, T. A., Vlaar, E., Kooij, G., Jongenelen, C. A. M., Geurts, J. J. G., & van Dam, A.-M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0850-z · Cited by 147 · cited 1×
“…express CD68 in control tissue as well as in early MS lesions (Zrzavy et al., 2017) indicating that resident microglia (expressing P2ry12 and TMEM119) express activation markers the balance of which is likely regulated by inflammatory cytokines in their environment (van Wageningen et al., 2019).”
BackgroundA quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138 · cited 10×
“3.2 | Identity of TSPO+ cells in MS lesions As we reported previously (Nutma et al., 2019) TSPO + HLA cells were observed in control, NAWM and lesional white matter (Figure 3 (a)).”
BackgroundResultInfluentialSelf-citationDickens, A. M., Vainio, S., Marjamäki, P., Johansson, J., Lehtiniemi, P., Rokka, J., Rinne, J., Solin, O., Haaparanta-Solin, M., Jones, P. A., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.125625 · Cited by 138 · cited 1×
“This is consistent with our previous findings, showing that approximately 65% of the total population of TSPO+ cells in inactive lesions are astrocytes (Dickens et al., 2014; Kaunzner et al., 2019; Nutma et al., 2019).”
ResultIn Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with18F-PBR111 PET
Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.135129 · Cited by 100 · cited 2×
“Cells expressing TSPO and microglia/macrophage markers were most abundant in active lesion areas, as expected from PET data showing increased TSPO signal in lesions (Colasanti et al., 2014; Datta et al., 2017; Debruyne et al., 2003; Unterrainer et al., 2018; Vomacka et al., 2017).”
BackgroundSelf-citationVeronese, M., Reis Marques, T., Bloomfield, P. S., Rizzo, G., Singh, N., Jones, D., Agushi, E., Mosses, D., Bertoldo, A., Howes, O., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17712388 · Cited by 65
Impact of Endothelial 18-kDa Translocator Protein on the Quantification of18F-DPA-714
Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M.-A., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I., & Bottlaender, M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195396 · Cited by 63 · cited 2×
“Although TSPO is also expressed in endothelial cells an can be found at low levels in oligodendrocytes and neurons, our data suggests that in the MS brain the largest proportion of TSPO PET signal in the white matter originates from microglia, except in the proportionally smaller volumes of inactive lesions, in which…”
BackgroundTranslocator protein 18 kDa (TSPO) expression in multiple sclerosis patients
Harberts, E., Datta, D., Chen, S., Wohler, J. E., Oh, U., & Jacobson, S. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9397-5 · Cited by 36
Cited by
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
The role of glial cells in multiple sclerosis disease progression
Healy, L. M., Stratton, J. A., Kuhlmann, T., & Antel, J. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00624-x · Cited by 152
Analyzing microglial phenotypes across neuropathologies: a practical guide
Schwabenland, M., Brück, W., Priller, J., Stadelmann, C., Lassmann, H., & Prinz, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02370-8 · Cited by 149
Positron emission tomography in multiple sclerosis - straight to the target
Bodini, B., Tonietto, M., Airas, L., & Stankoff, B. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00537-1 · Cited by 74
TSPO-detectable chronic active lesions predict disease progression in multiple sclerosis
Polvinen, E., Matilainen, M., Nylund, M., Sucksdorff, M., & Airas, L. M. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200133 · Cited by 36
Metadata
- Authors
- Nutma, E., Gebro, E., Marzin, M. C., van der Valk, P., Matthews, P. M., Owen, D. R., & Amor, S.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2021-06-19
- Volume
- 69
- Issue
- 10
- Pages
- 2447-2458
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W3172901398
- Cited by
- 92
- References
- 26
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.